Jon Mork

  • Senior consultant MD, PhD
  • +47 23 07 42 65
 

Publications 2018

Anderson KS, Mork J, Langseth H, Wallstrom G (2018)
Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer: Methodologic issues
Oral Oncol, 80, 93
DOI 10.1016/j.oraloncology.2018.02.013, PubMed 29606498

Publications 2017

Anderson KS, Wallstrom G, Langseth H, Posner M, Cheng JN, Alam R, Chowell D, Furre IE, Mork J (2017)
Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer
Oral Oncol, 73, 132-137
DOI 10.1016/j.oraloncology.2017.08.014, PubMed 28939065

Fossum GH, Lie AK, Jebsen P, Sandlie LE, Mork J (2017)
Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival
Eur Arch Otorhinolaryngol, 274 (11), 4003-4010
DOI 10.1007/s00405-017-4748-8, PubMed 28933005

Publications 2012

Nygård M, Aagnes B, Bray F, Møller B, Mork J (2012)
Population-based evidence of increased survival in human papillomavirus-related head and neck cancer
Eur J Cancer, 48 (9), 1341-6
DOI 10.1016/j.ejca.2012.03.014, PubMed 22516210

Publications 2010

König M, Mork J, Hall KS, Osnes T, Meling TR (2010)
Multimodal treatment of osteogenic sarcoma of the jaw
Skull Base, 20 (3), 207-12
DOI 10.1055/s-0029-1246221, PubMed 21318040

Mork J, Møller B, Dahl T, Bray F (2010)
Time trends in pharyngeal cancer incidence in Norway 1981-2005: a subsite analysis based on a reabstraction and recoding of registered cases
Cancer Causes Control, 21 (9), 1397-405
DOI 10.1007/s10552-010-9567-9, PubMed 20431937

Publications 2002

Annertz K, Anderson H, Biörklund A, Möller T, Kantola S, Mork J, Olsen JH, Wennerberg J (2002)
Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults
Int J Cancer, 101 (1), 95-9
DOI 10.1002/ijc.10577, PubMed 12209594

Page visits: 2288